Karra, H <br/><br/>
Cdc20 and securin overexpression predict short-term breast cancer survival.  [electronic resource] 

 -  British journal of cancer  Jun 2014 
 - 2905-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2014.252  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cdc20 Proteins--biosynthesis<br/>DNA--analysis<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Proteins--biosynthesis<br/>Securin--biosynthesis<br/>Treatment Outcome<br/>Triple Negative Breast Neoplasms--metabolism